Animal studies with reduced VEGF levels showed amyotrophic lateral sclerosis (ALS) in humans, and increased VEGF expression delayed neurodegeneration and prolonged survival in ALS mice [11]. The gene discussed is VEGFA; the disease is amyotrophic lateral sclerosis.